ClinicalTrials.gg
RecruitingNCT07082036HemiSymUpdated Jul 24, 2025

Stability of Hemiparetic Patients During a Daily Complex Task

An observational study in Hemiparesis, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-24.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

How we know

From the registry’s dates

  • Started Nov 2024; still recruiting 2 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
72
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 26 studies in Paresis with a site in France — 12 open to participants now, 12 under way, none of them phase 3. Paresis · France.

Started
2024
the only one that year
Observational
4 of 26
3 open now
Primary completion
2026-11
later than 4 of 11 live
Registered
21st of 26
by date
Lead sponsor
5 of 26
Assistance Publique - Hôpitaux de Paris

Among the 26 studies in Paresis with a site in France, this one is the only one that started in 2024, is one of 4 observational ones, reaches primary completion later than 4 of the 11 other live ones, and was the 21st registered.

Paresis

473 studies on the registry are indexed under Paresis; 121 are open to participants now.

Browse Paresis studies →

Open to participants now

12 of the 26 studies in Paresis with a site in France are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 84 Paresis studies recruiting now, 34 (40%) set no upper age limit and 27 (32%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Paresis with a site in France, or all of them as a file.
02

Study summary

Among the repercussions of hemiparesis following stroke, disturbed stability is responsible for a high risk of falls. Picking up objects from the ground, frequently trained in rehabilitation due to its risk of falling and its frequency in daily life, is a task requiring balance. To date, however, it has been little studied. We suggest that stability conditions the asymmetry adopted by patients. We hypothesise that asymmetric support at the expense of the paretic lower limb provides better stability during an unstable functional task (picking up an object from the ground) compared with the symmetrical support traditionally imposed in rehabilitation.

Postural control involves stability (maintaining balance despite constraints) and orientation (posture adopted, such as the distribution of supports). Hemiparetic patients show a lack of stability and, with regard to orientation, an asymmetry in the distribution of body weight to the detriment of the paretic limb. Symmetrisation of weight distribution has been one of the predominant concepts in rehabilitation.

Read the detailed description

To analyse the stability of hemiparetic stroke patients when picking up an object on the ground in a spontaneous condition compared with a condition of imposed support symmetry.

To analyse and compare the stability, spontaneous symmetry and duration of picking up the object in a complex situation (distant target) compared with the near target in stroke patients and healthy subjects.

To explore strategy and performance of picking up the object regarding clinical outcomes (falls, sensori-motor impairments, balance..) To compare strategy of patients with right and left stroke.

03

Conditions studied

  • Hemiparesis

Browse trials for

Keywords

  • Hemiparetic patients
  • Stability
  • Orientation
  • Postural control
  • Strategy
  • Motion
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Hemiparetic patients following stroke; Healthy subjects (same age, height, weight).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

All:

Male or female ≥ 18 years

For patients :

  • Haemiparesis after a single unilateral hemispheric Stroke.
  • Stroke ≥ 6 months
  • Asymmetry of support between the 2 lower limbs (distribution of body weight) in a standing position at the expense of the paretic lower limb > 10%.
  • Able to stand alone, without technical aids or equipment, with feet the width of the pelvis
  • Able to pick up an object from the ground alone (minimum score 3/4 item 9 of the Berg Balance Scale).
  • Patient informed and having signed a consent form

For healthy subjects:

- Similar characteristics (in terms of sex, age range and class) to those of one of the patients already included.

Exclusion criteria

Exclusion Criteria:

-

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
72 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. stability parameter: the range of the medio-lateral centre of pressure during the object picking up task

    Two forceplate platforms. 3 trials for each condition

    Time frame: at baseline

Secondary outcomes

  1. Velocity of the centre of pressure

    Mean velocity and in each place, in mm/s, obtained with forceplat plateforms under feet of participants during the object picking up task.

    Time frame: at baseline

  2. Ellipse area of the centre of pressure

    With 95% confidence, in mm², obtained with forceplat plateforms under feet of participants during the object picking up task

    Time frame: at baseline

  3. Range of the centre of pressure

    Range in antero-posterior plane, in mm, obtained with forceplat plateforms during the object picking up task

    Time frame: at baseline

  4. Percentage of weight bearing

    Under each lower limb, in %, obtained with forceplat plateforms during the object picking up task

    Time frame: at baseline

  5. Kinematics parameters

    range of movements of trunk, pelvis and lower limbs (hip, knee, ankle), in degrees, obtained with the optoelectronic system during the object picking up task

    Time frame: at baseline

  6. Questionnaires : Confidence perception and stability perception during the object picking up task

    On a visual scale 0 (no confidence) to 10 (perfect confidence)

    Time frame: at baseline

  7. Clinical scales - Berg balance scale

    Time frame: at baseline

  8. Clinical scales-Medical Research Council

    Time frame: at baseline

  9. Clinical scales-Modified Ashworth

    Time frame: at baseline

  10. Clinical scales-Nottingham Sensory Assessment

    Time frame: at baseline

  11. Clinical scales -Neglect and lateropulsion scale

    Time frame: at baseline

  12. Cognitive scale : Batterie Rapide d'Efficience Frontale

    Time frame: at baseline

  13. Activities-Specific Balance Confidence

    Time frame: at baseline

  14. Functional reach test

    In cm

    Time frame: at baseline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Nov 2026, 24 months after the start.

Of 22 observational studies under Paresis, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 68. This study's planned 24 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
May 21, 2025
First posted
Jul 24, 2025
StartActual
Nov 5, 2024
Primary completionEst.
Nov 2026
CompletionEst.
Nov 2026
Last update
Jul 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07082036
Responsible party
Sponsor
First posted
Jul 24, 2025
Start date
Nov 5, 2024
Primary completion
Nov 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Jul 24, 2025

Study contacts

Céline Bonnyaud, PhD
Contact
celine.bonnyaud@aphp.fr
+ 33 01 71 14 49 21
Céline Bonnyaud
principal investigator · Motion Analysis Laboratory, CHU Raymond Poincaré - APHP

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion